Navigation Links
China Shenghuo Announces Restated Results For Full Year 2007 & First Quarter 2008, Reports Results For Second & Third Quarter 2008
Date:11/20/2008

unting and legal expenses in connection with the restatement), expenses relating to business expansion, and the allowance for doubtful accounts due to the increase of trade receivables aging over one to two years.

Operating loss for the first nine months of 2008 was $1.63 million compared with operating income of $3.23 million for the same period of 2007.

Net loss the first nine months of 2008 was $2.24 million, or $0.11 loss per diluted share. This compares to a net income of $3.66 million, or $0.19 earnings per diluted share for the same period of 2007.

As of September 30, 2008, the Company's total cash and cash equivalents amounted to $1.08 million as compared with $2.80 million as of December 31, 2007. Total shareholders' equity amounted to $9.82 million as of September 30, 2008 compared with total shareholders' equity of $11.31 million as of December 31, 2007.

Following the completion of its independent internal investigation and financial restatement for the full year 2007 and the first quarter of 2008, as well as the filings of its quarterly reports for the second and third quarters of 2008, the Company will await confirmation from the NYSE Alternext US LLC (formerly the American Stock Exchange) (the "Exchange") that it has regained compliance with the Exchange's listing standards. The company will request that the Exchange permit its common stock to resume trading under the ticker symbol "KUN," shortly.

"We are very pleased to have the investigation and restatement behind us and are glad that our shares are expected to resume trading on the NYSE Alternext US LLC," said Mr. Gui Hua Lan, Chief Executive Officer of China Shenghuo. "I want to reiterate that after this rigorous process, I am very confident in the integrity of our results."

"As for our financial performance, our results for the first nine months of 2008 demonstrated measurable sales improve
'/>"/>

SOURCE China Shenghuo Pharmaceutical Holdings, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. ChinaBio(R) Inaugural Partnering Forum Scheduled for June 2009 in Shanghai, China
2. China Documents First Case of Tick-Borne Disease Spread
3. Drug Information Association (DIA) Opens New Office In China
4. China Healthcare Acquisition Corp Agrees to Terminate Agreement to Acquire Europe Asia Huadu Environment Holding Pte, Ltd.
5. China Information Security Technology, Inc. Issues Guidance & Discuss Outlook for 2009
6. China Bio-Immunity Corporation to Report Third Quarter 2008 Financial Results
7. Pantheon China Acquisition Corp. to Acquire China Cord Blood Services Corporation - Extension Proxy Filed With SEC
8. Measles Initiative Supports Disease Prevention for Children in Chinas Earthquake Zone
9. China Sky One Medical, Inc. Announces Record Third Quarter 2008 Results
10. China Pharma Holdings, Inc. Reports Third Quarter 2008 Financial Results and Corporate Updates
11. China Pharma Holdings, Inc. to Host Third Quarter 2008 Earnings Conference Call at 10 a.m. EST Friday November 7, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... (PRWEB) March 03, 2015 Findings could ... Researchers at UC Davis have developed and characterized a ... cells, causing them to self-destruct. This novel mechanism was ... for a usually fatal type of brain cancer – ... , The article, to be published in the ...
(Date:3/3/2015)... VA (PRWEB) March 03, 2015 Today ... the Portland-based maker of bike, skate, snow, water, and ... awareness about brain injury. The partnership kicks off with ... website at http://www.nutcasehelmets.com to BIAA during the ... Month. , Each year BIAA leads the nation in ...
(Date:3/3/2015)... US Air Purifiers LLC , an Illinois based ... to announce that all Rabbit brand air purifiers are back ... west coast port strikes. This news comes just in time, ... The port strikes, which have caused significant supply ... growth by as much as 1%, have hindered the restocking ...
(Date:3/3/2015)... DePuy Pinnacle hip lawsuits (( ... the artificial hip system caused recipients to suffer ... in the federal multidistrict litigation underway in U.S. ... the most recent Master Case List issued by ... hip replacement lawsuits are now pending in the ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 With a ... Georgia Health Policy Center (GHPC) has been named a ... (RWJF) to support the Bridging for Health: Improving Community ... regions, states and communities improve health and reduce disparities ... grant will support the work of the center and ...
Breaking Medicine News(10 mins):Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 2Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 3Health News:News: UC Davis Scientists Describe Novel Drug Mechanism That Fights Brain Cancer 4Health News:Brain Injury Association of America Partners with Nutcase Helmets to Raise Awareness About Brain Injury 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 2Health News:Rabbit Air Purifiers Back In Stock at US Air Purifiers LLC 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 2Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 3Health News:DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Comments on Growing Pinnacle Hip Litigation 4Health News:Robert Wood Johnson Foundation Names Georgia Health Policy Center National Center for Bridging for Health Initiative 2
... HealthDay Reporter , WEDNESDAY, March 16 (HealthDay News) ... a large hospital, more patients died, a new study discovered. ... nursing shortages and cost-cutting, in that the focus should shift ... research, appearing in the March 17 issue of the ...
... Washington, DC Stephen J. Teach, MD, MPH, Medical Director ... pediatric asthma care and research at Children,s National Medical Center, ... that may advance asthma treatment and outcomes, specifically for inner-city ... the National Institutes of Health (NIH) were published and released ...
... Reporter , WEDNESDAY, March 16 (HealthDay News) -- ... city children with the respiratory condition, and almost eliminated ... When added to standard asthma treatments, Xolair (omalizumab) decreased ... control, according to the study, which is published in ...
... It is no surprise to scientists that the largest social ... their face is fundamental to our social interactions, one of ... how our brain processes facial identity. In a ... scientists used an original approach a method that "shakes" ...
... State University shows that while the number of visits to ... park operations has been significantly reduced. The reduction in funding ... $20 billion in economic impact that state parks have on ... for operations puts stress on America,s state-park systems," says Dr. ...
... , AUGUSTA, Ga. A clinical trial using an all-natural ... percent of American adults, is under way at Georgia Health ... are as dry as if you,ve closed the faucet, and ... Stephen Hsu, Molecular and Cell Biologist and co-investigator of the ...
Cached Medicine News:Health News:When Nurse Staffing Drops, Mortality Rates Rise: Study 2Health News:Stephen J. Teach, MD, MPH, part of landmark study on pediatric asthma 2Health News:Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: Study 2Health News:Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: Study 3Health News:Innovative technique gives vision researchers insight into how people recognize faces 2Health News:Study shows attendance at state parks grows, even as funding decreases 2Health News:Clinical trial for dry mouth funded by international oral care award 2
(Date:3/3/2015)... March 3, 2015  American Biosurgical, LLC ("ABI") ... cable manufacturer actively engaged in the design, development ... the world,s leading medical device companies has announced ... low volume custom medical cable manufacturer based in ... MTI brand under the name MTI Medical Cables.  ...
(Date:3/3/2015)... -- Columbia Laboratories, Inc. (Nasdaq: CBRX ) (" ... pharmaceutical company focused on pharmaceuticals for women,s health, today ... ROTH Conference, which will take place from March 8-11 ... Point, California . Management,s presentation will take place ... (12:00 p.m. Eastern Time) in the Promenade room. ...
(Date:3/3/2015)... - Sante Medical Hair Restoration is now offering the ... The ARTAS Robotic System is a state-of-the-art ... for transplantation. This latest development in minimally-invasive hair ... linear scar. "The ARTAS technology extends ... surgery." says Dr. Louis Grondin , Medical ...
Breaking Medicine Technology:American Biosurgical Acquires MTI Corporation 2No linear scar. Permanent results. 2
... Children,s Oncology Group Report Shows the Addition of ... of Death by 30% in Osteosarcoma Patients, ... IDMI ) today announced the Journal of ... 3 mifamurtide (L-MTP-PE) clinical trial,(INT-0133), entitled "Osteosarcoma: The ...
... Show Subjects Receiving,Infrequently Administered Ustekinumab Maintained Improvement from Psoriasis ... ... SAN ANTONIO, Feb. 2 One-year data from a second,double-blind, ... weeks provided sustained, clinically meaningful,improvement in the treatment of moderate ...
Cached Medicine Technology:IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 2IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 3IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 4IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 5IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 6IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology 7Ustekinumab (CNTO 1275) Phase 3 Data Show Long-Term Improvement Of Chronic Plaque Psoriasis 2Ustekinumab (CNTO 1275) Phase 3 Data Show Long-Term Improvement Of Chronic Plaque Psoriasis 3Ustekinumab (CNTO 1275) Phase 3 Data Show Long-Term Improvement Of Chronic Plaque Psoriasis 4Ustekinumab (CNTO 1275) Phase 3 Data Show Long-Term Improvement Of Chronic Plaque Psoriasis 5
... low cost, low volume alternative. Whole blood is ... separated from whole blood by centrifugation in a ... the Cebus single use cartridge. The cartridge is ... activate the concentrating process. Finally, the cartridge is ...
Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
... device restores lordosis and ... less reaming of the ... Danek's Tapered Laparoscopic Instruments ... and reproducibly place the ...
3D Cranial is the most widely used surgical navigation software. Navigate with confidence and ease with displayed Zone of Accuracy and several fully automated features. 3D Cranial offers seamless int...
Medicine Products: